Basit öğe kaydını göster

dc.contributor.authorAltintas, Ayse
dc.contributor.authorDeniz, Gunnur
dc.contributor.authorAktas-Cetin, Esin
dc.contributor.authorTahrali, Ilhan
dc.contributor.authorKucuksezer, Umut Can
dc.contributor.authorUygunoglu, Ugur
dc.contributor.authorAkdeniz, Nilgün
dc.date.accessioned2021-03-03T20:20:44Z
dc.date.available2021-03-03T20:20:44Z
dc.identifier.citationTahrali I., Kucuksezer U. C. , Altintas A., Uygunoglu U., Akdeniz N., Aktas-Cetin E., Deniz G., "Dysfunction of CD3(-)CD16(+)CD56(dim) and CD3(-)CD16(-)CD56(bright) NK cell subsets in RR-MS patients", CLINICAL IMMUNOLOGY, cilt.193, ss.88-97, 2018
dc.identifier.issn1521-6616
dc.identifier.othervv_1032021
dc.identifier.otherav_5968a524-afc4-46c9-a9c1-83caaadcc5cc
dc.identifier.urihttp://hdl.handle.net/20.500.12627/62905
dc.identifier.urihttps://doi.org/10.1016/j.clim.2018.02.005
dc.description.abstractMultiple sclerosis (MS), is a chronic inflammatory disease of central nervous system with unclear etiology. Relapsing-remitting (RR)-MS is the most frequent subtype of disease. Natural Killer (NK) cells have roles in cytotoxicity and immune regulation by cytokine secretions, with uncertain contribution to MS pathogenesis. This study aimed to explore contribution of NK cells to MS pathogenesis. Percentages of CD3(-)CD16(+)CD56(+) total NK cells, CD3(-)CD16(+)CD56(dim) and CD3(-)CD16(-)CD56(bright) NK cell subsets, NK cytotoxicity and intracellular IFN-gamma, IL-10 and IL-22 levels were investigated in patients with RR-MS and clinically isolated syndrome (CIS) as well as healthy subjects. Decreased IFN-gamma and increased IL-22 production might have detrimental effects on the clinical course of RR-MS. Impaired cytotoxicity is correlated with disease duration in RR-MS. These findings support the possible contribution of NK cells to RR-MS immuno-pathogenesis. (C) 2018 Published by Elsevier Inc.
dc.language.isoeng
dc.subjectYaşam Bilimleri
dc.subjectİmmünoloji
dc.subjectTemel Bilimler
dc.subjectYaşam Bilimleri (LIFE)
dc.titleDysfunction of CD3(-)CD16(+)CD56(dim) and CD3(-)CD16(-)CD56(bright) NK cell subsets in RR-MS patients
dc.typeMakale
dc.relation.journalCLINICAL IMMUNOLOGY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume193
dc.identifier.startpage88
dc.identifier.endpage97
dc.contributor.firstauthorID45861


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster